tiprankstipranks
MoonLake Immunotherapeutics (MLTX)
NASDAQ:MLTX
US Market

MoonLake Immunotherapeutics (MLTX) Financial Statements

288 Followers

MoonLake Immunotherapeutics Financial Overview

MoonLake Immunotherapeutics's market cap is currently ―. The company's EPS TTM is $-0.75; its P/E ratio is -56.00; MoonLake Immunotherapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue----$ -2.30M
Gross Profit----$ -2.30M
EBIT-$ -11.59M$ -12.34M$ -12.21M$ -29.62M
EBITDA-$ -11.59M-$ -12.20M$ -29.61M
Net Income Common Stockholders$ -4.89M$ -9.43M$ -10.14M$ -9.00M$ -25.04M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 511.01M$ 495.98M$ 501.79M$ 63.05M$ 72.11M
Total Assets$ 526.54M$ 500.22M$ 506.62M$ 66.75M$ 76.84M
Total Debt$ 3.70M$ 169.42K$ 211.24K$ 246.25K$ 282.58K
Net Debt$ -507.31M$ -495.81M$ -501.58M$ -62.80M$ -71.83M
Total Liabilities$ 13.05M$ 10.58M$ 7.51M$ 7.68M$ 8.08M
Stockholders Equity$ 495.68M$ 424.93M$ 489.80M$ 42.00M$ 48.90M
Cash Flow-
Free Cash Flow-$ -9.22M-$ -9.01M$ -11.60M
Operating Cash Flow$ -12.34M$ -9.22M-$ -9.01M$ -11.60M
Investing Cash Flow$ 116.87M$ -174.38M-$ 19.65M$ 9.90M
Financing Cash Flow$ 28.42M---$ 3.79K
Currency in USD

MoonLake Immunotherapeutics Earnings and Revenue History

MoonLake Immunotherapeutics Debt to Assets

MoonLake Immunotherapeutics Cash Flow

MoonLake Immunotherapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis